Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DHODH | Q02127 | 7/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.56 |
| ▸ | PDE10A | Q9Y233 | 5/20 | 0.50 |
| ▸ | CLK1 | P49759 | 1/20 | 0.50 |
| ▸ | CDK9 | P50750 | 1/20 | 0.50 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.50 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.50 |
| ▸ | DYRK2 | Q92630 | 1/20 | 0.50 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.50 |
| ▸ | DYRK1B | Q9Y463 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 3/20 | 0.46 |
| ▸ | MAOA | P21397 | 1/20 | 0.46 |
| ▸ | MAOB | P27338 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | GUSB | P08236 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL9597546 | 0.98 | DHODH (0.57) | DHODHKMT2APDE10ACLK1CDK9 | |
| SCHEMBL14917525 | 0.81 | DHODH (0.53) | DHODHKMT2APDE10ALMNATSHR | |
| SCHEMBL7590081 | 0.80 | PDE10A (0.58) | DHODHKMT2APDE10ALMNATSHR | |
| SCHEMBL27802771 | 0.80 | PDE10A (0.50) | DHODHKMT2APDE10ALMNATSHR | |
| SCHEMBL29377848 | 0.80 | PDE10A (0.66) | DHODHKMT2APDE10ACLK4LMNA | |
| SCHEMBL641899 | 0.80 | PDE10A (0.66) | DHODHKMT2APDE10ACLK4LMNA | |
| SCHEMBL10476973 | 0.79 | DHODH (0.54) | DHODHKMT2APDE10ALMNATSHR | |
| Hydrochloric Acid SCHEMBL9842693 | 0.79 | PDE10A (0.57) | DHODHKMT2APDE10ALMNATSHR | |
| SCHEMBL7534026 | 0.78 | PDE10A (0.51) | DHODHKMT2APDE10ALMNATSHR | |
| Iodide SCHEMBL8029601 | 0.78 | PDE10A (0.63) | DHODHKMT2APDE10ACLK4LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110082279-A1 | Chemiluminescent Compounds | GEN-PROBE INCORPORATED (US) | 2011-04-07 | — | — | US | disclosed |
| EP-1658503-B1 | CHEMILUMINESCENT COMPOUNDS | MOLECULAR LIGHT TECH RES LTD (GB) | 2009-11-18 | — | — | EP | disclosed |
| US-20070166759-A1 | Chemiluminescent compounds | GEN-PROBE CARDIFF, LTD. (GB) | 2007-07-19 | — | — | US | disclosed |
| EP-1029016-B1 | NOVEL CHEMILUMINESCENT LABELING COMPOUNDS | LUMIGEN INC (US) | 2007-03-07 | — | — | EP | disclosed |
| EP-1658503-A1 | CHEMILUMINESCENT COMPOUNDS | Molecular Light Technology Research Limited (GB) | 2006-05-24 | — | — | EP | disclosed |
| EP-1005649-B1 | NON-ENZYMATIC METHODS OF GENERATING CHEMILUMINESCENCE FROM ACRIDAN ALKENES | LUMIGEN INC (US) | 2006-04-12 | — | — | EP | disclosed |
| WO-2005022161-A1 | CHEMILUMINESCENT COMPOUNDS | MOLECULAR LIGHT TECHNOLOGY RESEARCH LIMITED (GB) | 2005-03-10 | — | — | WO | disclosed |
| EP-1029016-A4 | NOVEL CHEMILUMINESCENT LABELING COMPOUNDS | LUMIGEN INC (US) | 2003-06-25 | — | — | EP | disclosed |
| EP-1005649-A4 | NON-ENZYMATIC METHODS OF GENERATING CHEMILUMINESCENCE FROM ACRIDAN ALKENES | LUMIGEN INC (US) | 2003-06-18 | — | — | EP | disclosed |
| EP-0625510-B1 | Novel N-alkylacridan carboxyl derivatives useful for chemiluminescent detection | LUMIGEN INC (US) | 2003-04-02 | — | — | EP | disclosed |
| EP-0778946-A4 | NOVEL METHOD AND KITS FOR PRODUCING LIGHT FROM AN ACRIDAN COMPOUND | LUMIGEN INC (US) | 1999-01-27 | — | — | EP | disclosed |
| EP-0844246-A1 | REAGENTS FOR LABELING SH GROUPS, PROCESS FOR THE PREPARATION OF THEM, AND METHOD FOR LABELING WITH THEM | SS Pharmaceutical Co., Ltd. (JP) | 1998-05-27 | — | — | EP | disclosed |
| US-5723295-A | MULTISTAGE CHEMILUMINESCENT ASSAY WITH PEROXIDASE ENZYME, PH ADJUSTMENT | LUMIGEN, INC. (US) | 1998-03-03 | — | — | US | disclosed |
| CN-1161083-A | Novel method and kits for producing light from 9,10-azetine compound | LUMIGEN INC (US) | 1997-10-01 | — | — | CN | disclosed |
| US-5670644-A | CHEMILUMINESCENT REACTIONS, PEROXIDASE AND PH FOR IMMUNOASSAY | LUMIGEN, INC. (US) | 1997-09-23 | — | — | US | disclosed |
| EP-0778946-A1 | NOVEL METHOD AND KITS FOR PRODUCING LIGHT FROM AN ACRIDAN COMPOUND | LUMIGEN, INC. (US) | 1997-06-18 | — | — | EP | disclosed |
| WO-1996007912-A1 | NOVEL METHOD AND KITS FOR PRODUCING LIGHT FROM AN ACRIDAN COMPOUND | LUMIGEN, INC. (US) | 1996-03-14 | — | — | WO | disclosed |
| US-5491072-A | N-alkylacridan carboxyl derivatives useful for chemiluminescent detection | LUMIGEN, INC. (US) | 1996-02-13 | — | — | US | disclosed |
| WO-1994026927-A1 | NOVEL N-ALKYLACRIDAN CARBOXYL DERIVATIVES USEFUL FOR CHEMILUMINESCENT DETECTION | LUMIGEN, INC. (US) | 1994-11-24 | — | — | WO | disclosed |
| EP-0625510-A2 | Novel N-alkylacridan carboxyl derivatives useful for chemiluminescent detection | LUMIGEN, INC. (US) | 1994-11-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070166759-A1 | Chemiluminescent compounds | CBR3, CBR1, LTC4S | DHODH 2354/4885KMT2A 3854/4885PDE10A 183/4885 |
| US-20110082279-A1 | Chemiluminescent Compounds | CBR3, LTC4S, CBR1 | DHODH 2434/4885KMT2A 3896/4885PDE10A 202/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.